Global gene therapy market is estimated to be over US$ 411.2 Mn in 2018. It is anticipated to grow at a double-digit CAGR of 33.1% from 2019 to 2030.
Gene therapy is a trial technique that makes use of genes to prevent or treat diseases. In the near future, this technique will enable the doctors to cure a disorder through inserting a gene directly in the candidate’s cells instead of performing surgery or making use of drugs. Currently, researchers across the globe are experimenting and examining multiple approaches to gene therapy, such as replacement of a muted gene that results in disease with healthy duplication of gene. They are also studying to inactivate or destroy the muted gene that is not properly functioning. In addition, experiment includes the introduction of a new gene in the candidate’s body to fight a disease.
Though the gene therapy is promising treatment alternative for numerous diseases, few types of cancers, and also infections, the technique is considered risky with extensive study to make it safe and more effective. The said therapy is today being tested to make effective for diseases that have no cure yet. The therapy is specially designed to launch genetic material in cells to compensate the abnormal genes or also to produce a beneficial protein. In case the mutated gene makes required protein to be missing or faulty, the therapy can potentially introduce normal gene copy and restore the protein’s function.
Download PDF for Deep Analysis on COVID-19’s Impact on “Gene Therapy Market” @
Gene Therapy Market Prominent Players
Some of the prominent players in the global gene therapy market include Novartis AG, UniQure N.V., Regenxbio Inc., Sibiono GeneTech Co. Ltd., Amgen Inc., Voyager Therapeutics, Sarepta Therapeutics, Inc., Spark Therapeutics, Inc., Audentes Therapeutics, and Orchard Therapeutics plc, among others.
Europe is estimated to account for the highest CAGR in gene therapy market over the forecast period. Product approvals and strong product pipelines are likely to propel the European market in the coming years. Moreover, the increasing focus of key players in this region on receiving approvals for gene therapy products and collaborations & agreements among them for further developments in these products are anticipated to boost the market extensively during the forecast period.
Segmentation Based on:
Gene Therapy Market by Type –
growth factors, r
eceptors, and others.
Gene Therapy Market by Application –
infectious diseases, and others.
Key Questions That the Report Answers From Geographic Standpoint
The geographic scope of the report considers North America, Europe, and the Rest of the World (RoW). The report will decipher which regional market is currently dominating and which regional market is likely to witness the highest CAGR in the coming years.
The report will also provide insights on country-level markets, which are driving various regional markets
Comprehensive qualitative and quantitative insights will be provided for both regional & country-level markets
Ask For Discount @ https://www.marketindustryreports.com/discount/149
Table of Contents
- Market Definition
- Market Classification
- Geographic Scope
- Years Considered for the Study: Historical Years – 2016 & 2017; Base Year – 2018; Forecast Years – 2019 to 2030
- Currency Used
- RESEARCH METHODOLOGY
- Research Framework
- Data Collection Technique
- Data Sources
- Secondary Sources
- Primary Sources
- Market Estimation Methodology
- Bottom Up Approach
- Top Down Approach
- Data Validation and Triangulation
- Market Forecast Model
- Limitations/Assumptions of the Study
- ABSTRACT OF THE STUDY
- MARKET DYNAMICS ASSESSMENT
- UNIQUE SELLING PROPOSITIONS (USPs)
- Epidemiological Assessment: Chronic Respiratory Diseases
- Key Product Assessment
Ask for Free Customization: https://www.marketindustryreports.com/free-customization/149
Market Industry Reports is at the forefront of innovation to address the worldwide industry trends and opportunities. We identified the caliber of market dynamics & hence we excel in the areas of innovation and optimization, integrity, curiosity, customer and brand experience, and strategic business intelligence through our research.
Phone: +1 347 767 5477 ( US ) + 91 8956 767 535 ( IN ) + 44 131 463 4161 ( UK )